SQZ Biotechnologies Company (SQZB)
USD 0.03
(0.0%)
USD 0.03
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 | 85.61 Million USD | 0.92% |
| 2021 | 84.83 Million USD | 38.82% |
| 2020 | 61.11 Million USD | 22.18% |
| 2019 | 50.01 Million USD | 56.28% |
| 2018 | 32 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q2 | 15.03 Million USD | -1.09% |
| 2023 Q1 | 15.2 Million USD | -14.2% |
| 2023 Q3 | 13.88 Million USD | -7.64% |
| 2022 FY | 85.61 Million USD | 0.92% |
| 2022 Q1 | 21.17 Million USD | -1.38% |
| 2022 Q4 | 17.72 Million USD | -25.23% |
| 2022 Q2 | 23.03 Million USD | 8.79% |
| 2022 Q3 | 23.69 Million USD | 2.9% |
| 2021 Q3 | 24.43 Million USD | 0.0% |
| 2021 FY | 84.83 Million USD | 38.82% |
| 2021 Q4 | 21.46 Million USD | -12.13% |
| 2020 FY | 61.11 Million USD | 22.18% |
| 2019 FY | 50.01 Million USD | 56.28% |
| 2018 FY | 32 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 1.33 Million USD | -6311.338% |
| Arch Therapeutics, Inc. | 5.04 Million USD | -1598.101% |
| Evofem Biosciences, Inc. | 29.55 Million USD | -189.713% |
| Nascent Biotech, Inc. | 2.22 Million USD | -3739.625% |
| Rebus Holdings, Inc. | 664 Thousand USD | -12794.428% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | -129.815% |
| Qrons Inc. | 643.67 Thousand USD | -13201.547% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -21878.047% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | -49.058% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -20507.299% |
| Skye Bioscience, Inc. | 13.54 Million USD | -531.989% |
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | 1.344% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -1640.962% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -32613.219% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | -2835.943% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -5600.716% |
| Mesoblast Limited | 5.9 Million USD | -1350.678% |
| Marizyme, Inc. | 19.23 Million USD | -345.009% |
| Genus plc | 147.7 Million USD | 42.032% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | -875.245% |
| Pharming Group N.V. | 225.49 Million USD | 62.03% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | -4079.177% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -6282.119% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | -926.73% |
| ContraFect Corporation | 56.88 Million USD | -50.502% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | -1842.059% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -5689.95% |
| IMV Inc. | 37.7 Million USD | -127.051% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | -2968.389% |
| MultiCell Technologies, Inc. | 567.42 USD | -15089075.567% |
| ONE Bio Corp. | 6.44 Million USD | -1228.685% |
| Accustem Sciences Inc. | 3.74 Million USD | -2185.356% |
| RVL Pharmaceuticals plc | 85.94 Million USD | 0.379% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 531.96 Thousand USD | -15994.947% |
| Q BioMed Inc. | 3.43 Million USD | -2391.367% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | -246.425% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | -3158.546% |
| Biomind Labs Inc. | 994.18 Thousand USD | -8512.005% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | 13.804% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -4765.606% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | -1174.469% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -4492.382% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 342576.0% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | -434.777% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -4565.644% |
| GB Sciences, Inc. | 1.42 Million USD | -5927.347% |
| Alpha Cognition Inc. | 9.7 Million USD | -782.161% |
| HST Global, Inc. | 140.9 Thousand USD | -60662.773% |
| CSL Limited | 3.44 Billion USD | 97.518% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -7511.187% |
| Halberd Corporation | 74.84 Thousand USD | -114299.669% |
| Enzolytics Inc. | 2.17 Million USD | -3828.365% |
| Agentix Corp. | 1.37 Million USD | -6141.562% |
| Resverlogix Corp. | 12.71 Million USD | -573.529% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | -2245.272% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.53 Billion USD | 94.417% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -8101.054% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | -3460.139% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -5321.137% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | -2414.524% |
| AVAX Technologies, Inc. | 7.31 Million USD | -1071.216% |
| Zenith Capital Corp. | 8.94 Million USD | -857.386% |
| Genscript Biotech Corporation | 825.34 Million USD | 89.626% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -491370.065% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | -3387.085% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -49820.995% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | -4357.22% |
| Kadimastem Ltd | 2.41 Million USD | -3452.491% |
| Helix BioMedix, Inc. | 1.97 Million USD | -4241.659% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 10.86 Million USD | -687.881% |
| BioStem Technologies, Inc. | 22.97 Million USD | -272.665% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -47076.902% |
| LadRx Corporation | 3.81 Million USD | -2146.162% |
| Cell Source, Inc. | 4.32 Million USD | -1879.472% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -9171.042% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -9171.042% |
| NovAccess Global Inc. | 2.46 Million USD | -3370.908% |
| Affymax, Inc. | 39.38 Million USD | -117.384% |
| Itoco Inc. | 919.14 Thousand USD | -9215.09% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | -1920.072% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -7551.385% |
| Mobile Lads Corp. | 554.54 Thousand USD | -15339.477% |
| CytoDyn Inc. | 18.05 Million USD | -374.133% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -340076.407% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -38803.934% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -5930.39% |
| SYBLEU INC | 160.87 Thousand USD | -53120.493% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -4613.872% |
| International Stem Cell Corporation | 5.27 Million USD | -1524.341% |
| Bioxytran, Inc. | 3.82 Million USD | -2141.249% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -162543.897% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -420776.96% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | -136.086% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -5191.656% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -11535.625% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | -2652.138% |
| Neutra Corp. | 243.82 Thousand USD | -35015.515% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -390.457% |
| PureTech Health plc | 144.59 Million USD | 40.788% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | -317.86% |
| IXICO plc | 4.7 Million USD | -1718.972% |
| IntelGenx Technologies Corp. | 8.79 Million USD | -873.275% |
| Gelesis Holdings, Inc. | 117.74 Million USD | 27.286% |
| CSL Limited | 3.89 Billion USD | 97.801% |
| Cellectis S.A. | 97.32 Million USD | 12.023% |